Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis

• Published in: PloS one 2018-08, Vol.13 (8), p.e0202686-e0202686
• Main Authors: Peiseler, Moritz, Reiners, David, Pinnschmidt, Hans O, Sebode, Marcial, Jung, Franziska, Hartl, Johannes, Zenouzi, Roman, Ehlken, Hanno, Groth, Stefan, Schachschal, Guido, Rösch, Thomas, Weiler-Normann, Christina, Lohse, Ansgar W, Schramm, Christoph
• Format: Article
• Language: English
• Subjects: Adult; Aged; Alkaline Phosphatase - blood; Bile; Bilirubin; Bilirubin - blood; Biology and Life Sciences; Cholangiopancreatography, Endoscopic Retrograde - adverse effects; Cholangitis; Cholangitis, Sclerosing - diagnosis; Cholangitis, Sclerosing - etiology; Cholestasis; Cholestasis - diagnosis; Cholestasis - etiology; Chronic kidney failure; Cirrhosis; Complications; Complications and side effects; Data processing; Diagnosis; Disease; Endoscopes; Endoscopy; Female; Gastroenterology; Hepatology; Humans; Implants; Interdisciplinary aspects; Laboratories; Liver; Liver cirrhosis; Liver Cirrhosis - complications; Liver Cirrhosis - pathology; Liver transplantation; Logistic Models; Male; Medicine; Medicine and Health Sciences; Middle Aged; Multivariate analysis; Pancreatitis; Patients; Physical Sciences; Postoperative Complications; Regression analysis; Research and Analysis Methods; Retrospective Studies; Risk analysis; Risk Factors; Severity of Illness Index; Sex Factors; Sphincterotomy - adverse effects; Stents - adverse effects; Surgery; Surgical implants
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0202686

Endoscopic retrograde cholangiography (ERC) is a mainstay of therapy in patients with primary sclerosing cholangitis (PSC) and obstructive cholestasis. Patients with liver cirrhosis have an increased risk of surgical complications and are more susceptible to infections. Since PSC often progresses to cirrhosis, we aimed to assess whether ERC is associated with increased risk of complications in patients with PSC and cirrhosis. Out of 383 patients with PSC, 208 patients received endoscopic treatment between 2009-2017. Seventy patients had cirrhosis when ERC was performed and 138 patients had no signs of cirrhosis. Overall, 663 ERC procedures were analysed, with 250 ERC in patients with cirrhosis and 413 ERC in patients without cirrhosis. Data were analysed retrospectively from a prospectively acquired database using repeated measures logistic regression. Overall, 40 procedure-related complications were documented in 663 ERC interventions (6%). The rate of complications was similar between patients with and without cirrhosis (4.4% vs. 7.0%). First-time ERC was associated with a higher risk of complications (17.5% vs. 4.9%). Biliary sphincterotomy, stent placement and female sex, but not presence of liver cirrhosis, were identified as risk factors for overall complications in multivariate analysis. Patients without cirrhosis showed a significant decline of ALP and bilirubin levels after the first two interventions. In contrast, in patients with cirrhosis, ALP and bilirubin levels did not significantly decline after ERC. In patients with PSC, cirrhosis was not a risk factor for post-ERC complications. Therefore, cirrhosis should not preclude endoscopic intervention in patients with clear clinical indication.